Luye Pharma Group Ltd. (LYPHF)

PNK: LYPHF · Real-Time Price · USD

0.27

0.01 (5.80%)

At close: Apr 29, 2025, 9:30 AM

Luye Pharma Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	3.07B	3.24B	2.9B	3.13B	2.85B	2.25B	2.95B	2.58B	2.96B	3.23B	3.13B	2.97B	2.2B	1.96B	1.85B	1.43B	1.49B
Cost of Revenue	996.03M	978.16M	960.75M	1.04B	800.74M	805.5M	997.98M	784.69M	764.34M	779.68M	699.01M	676.69M	447.28M	427.08M	424.41M	304.95M	230.1M
Gross Profit	2.08B	2.26B	1.94B	2.09B	2.05B	1.44B	1.95B	1.79B	2.2B	2.45B	2.43B	2.29B	1.76B	1.54B	1.43B	1.12B	1.26B
Operating Income	657.64M	682.26M	207.1M	342.15M	446.99M	-158.54M	521.94M	239.8M	748.58M	776.42M	818.18M	815.4M	609.74M	531.59M	419.68M	350.77M	446.1M
Interest Income	n/a	209.94M	255.55M	131.56M	164.09M	94.13M	115.65M	121.21M	151.74M	89.05M	61.61M	73.32M	5.65M	23.7M	24.4M	22.83M	31.83M
Pretax Income	529.98M	471.11M	228.99M	294.39M	375.37M	-562.99M	488.44M	257.6M	684.58M	770.53M	863.4M	799.42M	674.05M	655.15M	461.17M	483.84M	490.88M
Net Income	387.84M	382.63M	149.98M	307.81M	297M	-520.98M	386.58M	167.17M	539.42M	664.93M	731.24M	740.49M	562.88M	596M	385.38M	466.97M	424.57M
Selling & General & Admin	1.14B	1.29B	1.41B	1.3B	1.1B	1.22B	1.05B	1.06B	1.12B	1.3B	1.27B	1.18B	947.05M	839.82M	878.36M	660.69M	727.97M
Research & Development	280.91M	291M	295.15M	430.99M	426.35M	379.41M	303.74M	463.73M	326.14M	383.32M	327.81M	293M	198.16M	163.04M	125.66M	109.67M	83.98M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.42B	1.58B	1.46B	1.66B	1.51B	1.91B	1.35B	1.41B	1.36B	1.59B	1.51B	1.42B	1.09B	905.53M	989.61M	662.76M	799.92M
Interest Expense	n/a	n/a	694.04M	578.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	850.83M	940.92M	1.12B	981.54M	838.15M	934.05M	770.73M	790.03M	873.86M	1.03B	1.01B	956.14M	729.79M	628.67M	657.87M	513.59M	608.04M
Cost & Expenses	2.42B	2.56B	2.42B	2.7B	2.31B	2.72B	2.35B	2.2B	2.13B	2.37B	2.21B	2.1B	1.54B	1.33B	1.41B	967.71M	1.03B
Income Tax Expense	91.8M	77.39M	83.63M	14.28M	72.19M	10.22M	80.45M	94.66M	144.25M	111.77M	168.06M	56.61M	110.87M	62.44M	73.31M	12.94M	67.79M
Shares Outstanding (Basic)	3.76B	3.76B	3.69B	3.48B	3.48B	3.48B	3.42B	3.19B	3.2B	3.22B	3.22B	3.22B	3.22B	3.24B	3.28B	3.32B	3.32B
Shares Outstanding (Diluted)	3.76B	3.76B	3.69B	3.48B	3.48B	3.48B	3.43B	3.19B	3.2B	3.22B	3.22B	3.22B	3.22B	3.24B	3.28B	3.32B	3.32B
EPS (Basic)	0.10	0.10	0.04	0.09	0.09	-0.15	0.11	0.05	0.17	0.20	0.22	0.22	0.17	0.18	0.12	0.14	0.13
EPS (Diluted)	0.10	0.10	0.04	0.09	0.09	-0.15	0.11	0.05	0.17	0.20	0.22	0.22	0.17	0.18	0.12	0.14	0.13
EBITDA	939.47M	1.03B	524.16M	666.26M	759.35M	128.12M	778.75M	477.43M	989.74M	999.47M	1.02B	973.78M	758.54M	682.58M	509.35M	424.08M	506.8M
EBIT	604.54M	680.34M	206.98M	342.15M	446.99M	-158.54M	521.94M	239.8M	748.58M	776.42M	818.18M	815.4M	609.74M	531.59M	419.68M	350.77M	446.1M
Depreciation & Amortization	334.93M	348.29M	317.18M	324.11M	312.36M	286.66M	256.82M	237.63M	241.16M	223.05M	204.98M	158.38M	148.81M	150.99M	89.67M	73.31M	60.7M